SCHEMBL13507360

SCHEMBL13507360

CN1c2cc(N(c3ccccc3)c3ccc(C(C)(C)C)cc3)ccc2-c2cc3c(c4cccc1c24)c1ccc(N(c2ccccc2)c2ccc(C(C)(C)C)cc2)cc1n3C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507232 0.97 KIF11 (0.31) KIF11
SCHEMBL13507379 0.89 BRD4 (0.31) —
SCHEMBL13507363 0.89 RXRA (0.31) —
SCHEMBL13508946 0.89 — —
SCHEMBL13507332 0.88 — —
SCHEMBL13507367 0.87 — —
SCHEMBL13507236 0.87 — —
SCHEMBL13507057 0.87 RXRA (0.35) —
SCHEMBL13508931 0.87 — —
SCHEMBL13507055 0.86 BRD4 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 KIF11 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback